IBGClass I
Trypsin
21 CFR 864.4400 / Pathology
IBG is the FDA product code for Trypsin, a class I device type, regulated under 21 CFR 864.4400. As of , FDA records hold 2 510(k) clearances under this code, the most recent dated , and one recall.
Classification record
- Product code
- IBG
- Device name
- Trypsin
- Regulation
- 21 CFR 864.4400
- Device class
- Class I
- Review panel
- Pathology
- Submission type
- 510(k) exempt
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 2
- Ingested recalls
- 1
Clearances, product code IBG
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1977 | 1 |
| 1980 | 1 |
Applicants with the most clearances
Product code IBG| Applicant | Clearances |
|---|---|
| Flow Laboratories, Inc. | 1 |
| Oxoid U.S.A., Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this code- Biogenex Laboratories, Inc.
- Bonraybio Co., Ltd.
- Bonraybio USA Corporation
- Guang XI Fulaiming Biopharmaceutics Co., Ltd.
- Himedia Laboratories Private Limited
- Lonza Verviers SRL.
- Lonza Walkersville, Inc.
- Medical Electronic Systems Ltd.
- Microgenics Corporation
- Scytek Laboratories, Inc.
- Ventana Medical Systems Inc
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
